FOI Biochip for Whole Genome Sequencing

Information

  • Research Project
  • 6991830
  • ApplicationId
    6991830
  • Core Project Number
    R43HG003778
  • Full Project Number
    1R43HG003778-01
  • Serial Number
    3778
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/23/2005 - 19 years ago
  • Project End Date
    3/31/2006 - 18 years ago
  • Program Officer Name
    SCHLOSS, JEFFERY
  • Budget Start Date
    9/23/2005 - 19 years ago
  • Budget End Date
    3/31/2006 - 18 years ago
  • Fiscal Year
    2005
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/22/2005 - 19 years ago
Organizations

FOI Biochip for Whole Genome Sequencing

DESCRIPTION (provided by applicant): The specific objective of the proposed innovative research is to demonstrate an advanced, second generation technique to manufacture fiber optic interrogated (FOI) microwell biochips that results in significant cost reduction, enabling a disposable product, while providing improved performance required for high speed genomic and proteomic analysis. The new manufacturing technique will utilize proven photolithography techniques to apply photocurable epoxy based photoresists to form permanent, well adhered microwells on the surface of fiber optic array plates. Fiber optic arrays offer important advantages as a platform for biosensors. Light incident on the top surface of the array is optically guided to the bottom surface, where it can be directly monitored optically. Incom Inc, a manufacturer of etched FOI microarray plates, will collaborate on the proposed research with 454 Life Sciences, a firm that has created a massively parallel whole genome sequencing system. When used in conjunction with an automated microfluidic genome sequencing system, the new biochip is expected to offer significant technical benefits that go beyond cost reduction; improved fluidic response, reduced reagent carry forward, and enhanced sealing and optical (CCD) interrogation of the biochip microwell. Disposable FOI Microwell biochips resulting from this development will have immediate commercial application to "whole genome sequencing". The ultimate beneficiaries of this technology will be the public served by a reliable, sensitive, high speed and low cost diagnostic technique.

IC Name
NATIONAL HUMAN GENOME RESEARCH INSTITUTE
  • Activity
    R43
  • Administering IC
    HG
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    172
  • Ed Inst. Type
  • Funding ICs
    NHGRI:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    INCOM, INC.
  • Organization Department
  • Organization DUNS
    055739791
  • Organization City
    CHARLTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01507
  • Organization District
    UNITED STATES